Picometrics Technologies , 478 rue de la Découverte , 31 670 Labège , France.
LAAS-CNRS , Université de Toulouse, CNRS , 7 Avenue du Colonel Roche , 31400 Toulouse , France.
Anal Chem. 2018 Mar 20;90(6):3766-3774. doi: 10.1021/acs.analchem.7b04034. Epub 2018 Mar 9.
We describe a technology to perform sizing and concentration analysis of double stranded DNA with a sensitivity of 10 fg/μL in an operating time of 20 min. The technology is operated automatically on a commercial capillary electrophoresis instrument using electro-hydrodynamic actuation. It relies on a new capillary device that achieves online concentration of DNA at the junction between two capillaries of different diameters, thanks to viscoelastic lift forces. Using a set of DNA ladders in the range of 100-1500 bp, we report a sizing accuracy and precision better than 3% and a concentration quantification precision of ∼20%. When the technology is applied to the analysis of clinical samples of circulating cell-free DNA (cfDNA), the measured cfDNA concentrations are in good correlation with those measured by digital PCR. Furthermore, the cfDNA size profiles indicate that the fraction of low molecular weight cfDNA in the range of 75-240 bp is a candidate biomarker to discriminate between healthy subjects and cancer patients. We conclude that our technology is efficient in analyzing highly diluted DNA samples and suggest that it will be helpful in translational and clinical research involving cfDNA.
我们描述了一种技术,可在 20 分钟的运行时间内对双链 DNA 进行尺寸分析和浓度分析,灵敏度为 10 fg/μL。该技术在商用毛细管电泳仪器上自动运行,使用电动驱动。它依赖于一种新的毛细管装置,该装置在两个不同直径的毛细管之间的连接处实现了 DNA 的在线浓缩,这要归功于粘弹性升力。使用一组 100-1500 bp 范围内的 DNA 梯,我们报告了优于 3%的尺寸精度和 20%左右的浓度定量精度。当该技术应用于循环游离 DNA (cfDNA) 的临床样本分析时,测量的 cfDNA 浓度与数字 PCR 测量的浓度具有良好的相关性。此外,cfDNA 大小谱表明,75-240 bp 范围内低分子量 cfDNA 的分数是区分健康受试者和癌症患者的候选生物标志物。我们得出结论,我们的技术在分析高度稀释的 DNA 样本方面非常有效,并表明它将有助于涉及 cfDNA 的转化和临床研究。